OnKure Therapeutics, Inc. OKUR Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s operating lease liabilities (total)?
- OnKure Therapeutics, Inc. (OKUR) reported operating lease liabilities (total) of $409K in Q1 2026.
- How has OnKure Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- OnKure Therapeutics, Inc.'s operating lease liabilities (total) decreased by 57.2% year-over-year, from $955K to $409K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s operating lease liabilities (total) has grown at a -27.9% compound annual growth rate (CAGR), from $1.46M to $549K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.